期刊文献+

多发性骨髓瘤32例临床分析 被引量:7

Clinical Analysis on Multiple Myeloma of 32 Cases
下载PDF
导出
摘要 目的 :探讨多发性骨髓瘤的临床特征。方法 :采用回顾性分析的方法。结果 :该病发病缓急程度相差大 ,无症状期 2周至 4年不等 ,绝大多数病人有发烧、骨痛、乏力等症状和肝脾肿大、淋巴结肿大等体征 ,患者均有Ig异常 ,其中IgG异常者最常见。结论 :骨髓瘤预后差 ,VAD治疗方案疗效较好 。 Objective: To discuss the clinical features of multiple myeloma. Methods: Retrospective analysis was utilized. Results: 1.Moyeloma might be with insidious onset or acute onset and with wide range of asymptomatic period from 2 weeks to 4 years. 2.Most patients showed the symptoms of anemia, bone pain and infection and revealed the signs related to the enlargement of liver, spleen and lymphonode. 3.The hallmark of myeloma is the finding of a monoclonal paraprotein on serum protein electrophoresis, mainly IgG paraprotein. Conclusion:1.Myeloma is a disease of older adults (median age at presentation, 51 years). 2.Anemia is nearly universal, paraprotein is a hallmark. 3. The goal of treatment of myeloma is usually palliative. Treating patients with VAD regimen shows better outcome in both remission duration and longer survival.Additional IFN administration may also be beneficial.
出处 《宁夏医学院学报》 2002年第3期175-176,共2页 Journal of Ningxia Medical College
关键词 恶性肿瘤 VAD治疗方案 干扰素 多发性骨髓瘤 临床分析 myeloma paraprotein VAD regimen
  • 相关文献

参考文献2

二级参考文献1

共引文献11

同被引文献23

  • 1苏畅,罗绍凯,许丽梅,颜棉生.轻链型多发性骨髓瘤23例临床分析[J].中国全科医学,2004,7(18):1308-1309. 被引量:20
  • 2朱建忠,程玉卉,徐龙春,李庆国.MRI筛查多发性骨髓瘤病人腰椎损害的应用价值[J].泰山医学院学报,2001,22(4):276-278. 被引量:4
  • 3叶光强,黄礼传.多发性骨髓瘤22例临床分析[J].检验医学与临床,2007,4(5):420-420. 被引量:1
  • 4Oasparet toc. Stem cell transplantion for multiple myema[J].Cancer Control,2004,18(11):119-129.
  • 5Matsui M,Huffc A,Vala M,et al. Anti 2tumoracrivity ofinterferon-alpha in multiple myeloma:role of interleukin6 and tumor cell differentiation[J]. Br J Haematol, 2003,121 (8) : 251-258.
  • 6Robert K,Morie G,Thomas W,et al.Review of 1027 patiets with newly diagnosed multiple myeloma[J].Mayo Clin Proc,2003,78:21-33.
  • 7Knudsen L M,Hjorth M,Hippe E.Renal failure in multiple myeloma:reversibility and impact on the prognosis[J].Eur Haematol,2000,65:175-181.
  • 8朱立华,王建中.实验诊断学[M].北京:北京大学医学出版社,2008:115.
  • 9Knudsen LM,Hjorth M,Hippe E.Renal failure in multi-ple myeloma:reversibility and impact on the prognosis[J].Eur Haematol,2000,65(3):175-181.
  • 10Kneller A,Rasuda P,Hardan I.et a1.Therapy with thalidomide in refractory multiple myeloma patients the revival of an old drug.Br J Haematol,2000,108:39l-393.

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部